Evidence map›Paper›PMID 34736222›Full record

ArticleJMIR public health and surveillance2022

Risk Factors of COVID-19 Critical Outcomes in the Eastern Mediterranean Region: Multicountry Retrospective Study.

Faris Lami, Maisa Elfadul, Hiba Rashak, Mohannad Al Nsour, Hashaam Akhtar, Yousef Khader, Ahmed M Hussein, Mariam Naciri, Sahar Samy, Yasser Ghaleb and 10 more

Open access · goldAbstract read
In one paragraph

Article in JMIR public health and surveillance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 13 institutions in 9 countries.

Faris LamiDepartment of Community and Family Medicine, University of Baghdad, Baghdad, Iraq.ORCID 0000-0002-3673-3818
Maisa ElfadulPublic and Tropical Health Programs, Epidemiology and Biostatistics, University of Medical Sciences and Technology, Khartoum, Sudan.ORCID 0000-0003-2976-2642
Hiba RashakMinistry of Health, Directorate of Public Health, Baghdad, Iraq.ORCID 0000-0001-8670-4364
Mohannad Al NsourThe Eastern Mediterranean Public Health Network, Global Health Development, Amman, Jordan.ORCID 0000-0003-1212-1611
Hashaam AkhtarYusra Medical and Dental Collage, Yusra Institute of Pharmaceutical Sciences, Islamabad, Pakistan.ORCID 0000-0003-1913-831X
Yousef KhaderFaculty of Medicine, Department of Community Medicine, Public Health and Family Medicine, Jordan University of Science and Technology, Amman, Jordan.ORCID 0000-0002-7830-6857
Ahmed M HusseinPublic Health Department, Somali International University, Magadishu, Somalia.ORCID 0000-0002-9207-6576
Mariam NaciriResearch Center Biotechnology, Biodiversity and Environment, Laboratory of Biodiversity, Ecology and Genome, Biology Department, Faculty of Sciences, Mohammed V University, Rabat, Morocco.ORCID 0000-0002-1323-2068
Sahar SamyCommunicable Disease Control Department - Preventive Sector, Ministry of Health and Population, Cairo, Egypt.ORCID 0000-0002-4137-0273
Yasser GhalebYemen Field Epidemiology Training Program, Ministry of Public Health and Population, Sana'a, Yemen.ORCID 0000-0001-6697-0753
Hana TahaDepartment of Basic Medical Sciences, Faculty of Medicine, The Hashemite University, Zarqa, Jordan.ORCID 0000-0001-8710-8249
Alaa HusseinPublic Health Department, Ministry of Health, Babel Health Directorate, Babel, Iraq.ORCID 0000-0002-0644-9664
Nameer A AliPublic Health Department, Ministry of Health, Al-Rusafa Health Directorate, Baghdad, Iraq.ORCID 0000-0002-1837-5121
Raheem HusseinPublic Health Department, Ministry of Health, Al-Rusafa Health Directorate, Baghdad, Iraq.ORCID 0000-0001-9957-8176
Aamer IkramNational Institute of Health, Islamabad, Pakistan.ORCID 0000-0002-6440-750X
Fazal Ur RahmanMedical Unit 1 Benazir Bhutto Hospital, Rawalpindi Medical University, Rawalpindi, Pakistan.ORCID 0000-0003-4374-511X
Mohammad Mujeeb KhanInfectious Diseases Department, Rawalpindi Medical University, Rawalpindi, Pakistan.ORCID 0000-0003-1408-069X
Reema AdamFederal Ministry of Health, Directorate of Emergency and Humantarian Actions, Khartoum, Sudan.ORCID 0000-0002-0896-9911
Abdulrazaq Yusuf AhmedMinstry of Health, Demartino Hospital, Mogadishu, Somalia.ORCID 0000-0002-6985-1087
Salma AfifiMinistry of Health and Population, Cairo, Egypt.ORCID 0000-0001-7705-5999
Ministry of Health · IQMinistry of Health and Population · EGRawalpindi Medical University · PKEastern Mediterranean Public Health Network · JOEl Camino Hospital · USFederal Ministry of Health · SDHashemite University · JOJordan University of Science and Technology · JOMohammed V University · MANational Institute of Health · PKSana'a University · YEUniversity of Baghdad · IQUniversity of Medical Sciences and Technology · SD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe establishment of empirical evidence in the Eastern Mediterranean Region necessitates the implementation of wide-scale studies to describe the demographic, clinical features, and severity profile of patients with COVID-19.

objectiveThis study aims to assess the patterns of COVID-19 severity and mortality in seven countries, and to determine the risk factors of COVID-19 severity and mortality.

methodsThis multicountry study was based on a retrospective review of medical records of hospitalized patients confirmed to have COVID-19. This study includes data from Iraq, Pakistan, Sudan, Somalia, Morocco, Egypt, and Yemen. All demographic and clinical data were extracted from hospital records (paper files) by trained data collectors.

resultsA total of 4141 patients were included in this study from seven countries. Comorbidities were reported by nearly half of the patients, with hypertension (n=1021, 24.7%) and diabetes (n=939, 22.7%) being the most common. Older age, diabetes mellitus, hypertension, and heart diseases were significantly associated with COVID-19 severity and mortality. Ever smoking and renal diseases were significantly associated with severity but not mortality, while male gender, respiratory diseases, and malignancy were significantly associated with mortality but not severity.

conclusionsThe study confirms the role of comorbidities and demographic features on the severity and mortality of COVID-19. Understanding the contributing factors ensures attentive care and informs clinical management of patients with poorer prognoses in the early stages of diseases.

Indexed as

COVID-19EgyptHumansMaleMediterranean RegionRetrospective StudiesRisk FactorsCOVID-19critical outcomesdemographicimplementationmortalityoutcomepatternretrospectiveriskrisk factorseveritytrend

Identifiers

PMID34736222
PMCPMC8929409
OpenAlexW3203418099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.